# Down Syndrome Biomarker Initiative (DSBI)

> **NCT02141971** · — · COMPLETED · sponsor: **Michael Rafii** · enrollment: 12 (actual)

## Conditions studied

- Down Syndrome
- Alzheimer's Disease

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02141971
- **Lead sponsor:** Michael Rafii
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2013-06-01
- **Primary completion:** 2017-04-15
- **Final completion:** 2017-04-15
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2017-05-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02141971

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02141971, "Down Syndrome Biomarker Initiative (DSBI)". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT02141971. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*